Skip to main content

Archive

FTSE 100 weekly: Fresh scandal for G4S as SFO launches probe

G4S (LON:GFS) was engulfed in fresh scandal this week as the Serious Fraud Office launched a probe into claims the embattled security group overcharged the government for its electronic tags.

Justice Secretary Chris Grayling called for the SFO investigation after a review found the government had been paying over the odds by tens of millions of pounds.

Government services group Serco (LON:SRP) is also under investigation for overpriced tags used to keep tabs on offenders.

It follows last year’s Olympics scandal when G4S failed to summon enough security guards during the London Games.

Boss Nick Buckles survived an internal review but quit in May after a profit warning.

In a response to Grayling’s statement, the company called the Ministry of Justice an important customer and said it would act quickly to resolve the issue.

It has requested the full details of an audit by PricewaterhouseCoopers, but believes no allegations of “dishonesty or misconduct” are being aimed at the company.

Newly-installed CEO Ashley Almanza said: “G4S is committed to having close and open relationships with our customers and we strive to work in partnership for the mutual benefit of our organisations.

“We place the highest premium on customer service and integrity and therefore take very seriously the concerns expressed by the Ministry of Justice. We are determined to deal with these issues in a prompt and appropriate manner.”

In a statement, Serco said it was willing to repay any amount it owes and withdrew from the re-tendering process for electronic tagging.

Its South Yorkshire prisons contract is now under threat as a result of the probe.

The pair dropped to the bottom of the Footsie, hitting their lowest levels in four years.

It was not the only scandal to hit the Footsie this week.

Senior executives of Britain’s biggest drug company GlaxoSmithKline (LON:GSK) have admitted to bribery and tax violations charges in China, the authorities there have claimed.

It follows questioning by police in China about offering bribes to government officials, medical associations, hospitals and doctors to boost sales and prices, as well as faking receipts in a bid to pay less tax.

“After initial questioning the suspects have admitted to the crimes, and the investigation is ongoing,” read a statement from China’s ministry of public security.

It is as yet unknown how many staff are implicated.

On Monday, Glaxo said it was investigating allegations that its staff bent the law to market Botox in China.

Elsewhere on the top flight, there were more disappointing clothing sales from Marks & Spencer (LON:MKS), which recorded an eighth consecutive quarterly fall in general merchandise sales.

AB Foods (LON:ABF) showed M&S how things are done, with booming sales from Primark.

Sales at the budget clothing chain soared 22% higher in the 40 weeks to June 22 this year.

Fashion and luxury goods peddler Burberry (LON:BRBY) saw retail revenues in its first quarter rise far faster than the market had been expecting.

Retail revenue in the three months to the end of June was up 18% year-on-year on an underlying basis to £339mln. Like-for-like sales were up 13%, which the company said was a performance in line with its expectations for the quarter.

The company may have expected that sort of eye-catching performance but the City had not; UBS, for example, had predicted retail sales of £321mln and a mere 6% increase in LFL sales.

Oil giant Shell (LON:RDSB) surprised many in the City when it unveiled Ben van Beurden as its next chief executive.

The low-profile head of Shell’s refining and marketing arm, van Beurden is credited with reviving the fortunes of the ailing chemicals division.